| Date | Form | Description | Docs | XBRL | Pages |
| 01/28/00 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
60 | |
| 03/31/99 | 10-K/A | Annual report pursuant to section 13 and 15(d) |
|
13 | |
| 01/29/99 | 10-K405 | Annual report [Sections 13 and 15(d), S-K Item 405] |
|
42 | |
| 01/29/98 | 10-K405 | Annual report [Sections 13 and 15(d), S-K Item 405] |
|
40 | |
| 01/29/97 | 10-K405 | Annual report [Sections 13 and 15(d), S-K Item 405] |
|
35 | |
| 01/29/96 | 10-K405 | Annual report [Sections 13 and 15(d), S-K Item 405] |
|
44 |
- << Previous
- 1
- 2
- 3
- 4
- 5
Latest News & Events
Anixa Biosciences Announces Publication of Peer-Reviewed Journal Article in Clinical and Experimental Vaccine Research Highlighting Ovarian Cancer Vaccine Technology
Read More...Anixa Biosciences to Present at the 2022 H.C. Wainwright Global Investment Conference
Read More...Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
Read More...